Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BENOLIV is a hepatoprotective medication developed and marketed by Bennet Pharmaceuticals. It is a combination product primarily composed of silymarin, a standardized extract from the seeds of the milk thistle plant (*Silybum marianum*), and a B-complex vitamin supplement. Silymarin functions as an antioxidant, scavenging free radicals and inhibiting lipid peroxidation, while also stimulating protein synthesis to aid in the regeneration of hepatocytes. The inclusion of B-complex vitamins supports hepatic metabolic functions and addresses potential deficiencies common in patients with chronic liver disease. BENOLIV is indicated for the management of various hepatic conditions, including fatty liver, alcoholic liver disease, and chronic hepatitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BENOLIV.